Single Use Bioreactors Market 2028 By Product, Type, Application, End-User and Geography | The Insight Partners

report image

Single Use Bioreactors Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Single-Use Bioreactors System, Single-Use Media Bag, Single-Use Filtration Assemblies , Other); Type (Stirred Tank Single-Use Bioreactors, Bubble Column Single-Use Bioreactors, Wave Induced Single-Use Bioreactors); Molecule type (Monoclonal Antibodies, Vaccine, Stem Cells, Gene Modified Cells, Other Molecules); Cell Type (Mammalian Cells, Bacteria Cells, Yeast Cells, Other Cells); Application (Research and Development, Process Development, Bio Production , Other); End-User (Pharmaceutical and Biopharmaceutical Companies, Academic and Research Institutes, Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs)) and Geography

Report Code: TIPRE00022449 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

MARKET OVERVIEW

A single-use bioreactor, also called a disposable bioreactor, refers to a bioreactor with a disposable bag in place of a culture vessel. It is a bioreactor in which the plastic lining is in contact with the cell culture, and the lining is encased within a permanent structure. They have become an essential part of the biotechnology manufacturing facilities and perfectly suitable for the production of biopharmaceutical goods due to their high performance. They perform on an enhancing sensor system, designs, stirring mechanism, and film technology of single-use bioreactors. In addition, single-use bioreactors are comparatively safe, simple, and flexible.

MARKET SCOPE

The "Global Single Use Bioreactors Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the single use bioreactors market with detailed market segmentation by product, type, molecular type, cell type, application, end user, and geography. The report provides key statistics on the market status of the leading single use bioreactors market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •  Based on product, the global single use bioreactors market is segmented into single-use bioreactors system, single-use media bag, single-use filtration assemblies and other.
  •  On the basis of type, the market is bifurcated into stirred tank single-use bioreactors, bubble column single-use bioreactors, and wave induced single-use bioreactors.
  •  On the basis of molecular type, the market is bifurcated into monoclonal antibodies, vaccine, stem cells, gene modified cells, and other molecules.
  •  On the basis of cell type, the market is segmented into mammalian cells, bacteria cells, yeast cells, and other cells.
  •  On the basis of application, the market is bifurcated into research and development, process development, bio production and other.
  •  On the basis of end-users, the market is segmented into pharmaceutical and biopharmaceutical companies, academic and research institutes, contract research organizations (CROs) and contract manufacturing organizations (CMOs)

MARKET DYNAMICS
Drivers

  •  The growing number of clinical trials, rising demand for effective vaccines and medications, affordable cost of labor associated with it, and increasing geriatric population are major factors driving the growth of the single use bioreactors market.
  •  Increasing adoption of single-use bioreactors amongst small companies and startups, along with their commercial usages, cost-effectiveness, and lower downtime, boosts the market growth.
  •  Rising biopharmaceutical research and development expenditure and technological advancements in single-use bioreactors propel the growth of the market.
  •  The rising biopharmaceutical industry, increasing government initiatives to support the market, and increasing CROs and CMOs in the various developing economies are the factors favoring the market growth.

Restraints

  •  Administrating issues related to single-use bioreactors.
  •  Concerns regarding the leachable and extractable.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The single use bioreactors market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the single use bioreactors market in these regions.

IMPACT OF COVID-19 ON SINGLE USE BIOREACTORS MARKET

COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. With the rising pandemic, many biopharmaceutical companies are involved in developing vaccines in response to it. In the medical sector, single-use bioreactors are in high demand. This generates lucrative opportunities for companies engaged in this domain. Due to their unique ability to enhance flexibility, reduce investment, and limit operational costs, these reactors are used to manufacture drugs without any negotiations on their quality. A decrease in the pharmaceutical R&D expenditure and a drop in biologics sales in 2020 due to the outbreak will significantly impact the growth of the single-use bioreactors market. Biomanufacturing companies adopt for disposable components and key technologies like single-use equipment and chromatography resins to avoid contamination issues. The clinical and commercial manufacturing platforms are primarily supported by single-use equipment and systems. The applications of single-use bioreactors are broad, including academic to commercial-scale laboratories, drug discovery, and pharmaceuticals for the development of vaccines, cell culture, and more. Hence, the healthcare industry and bioprocessing manufacturing industries are affected positively in terms of revenue and funding, and the overall single-use bioreactors market is anticipated to witness substantial growth.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the single use bioreactors market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from single use bioreactors market are anticipated to have lucrative growth opportunities in the future with the rising demand for single use bioreactors in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the single use bioreactors market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  Merck KGaA
  •  Thermo Fisher Scientific
  •  Sartorius AG
  •  Cesco Bioengineering Co., LTD
  •  GE Healthcare,
  •  Solida Biotechnology GmbH
  •  Applikon Biotechnology
  •  Allergo
  •  Celltainer
  •  Pierre Guérin

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

The List of Companies

1. Merck KGaA
2. Thermo Fisher Scientific
3. Sartorius AG
4. Cesco Bioengineering Co., LTD
5. GE Healthcare
6. Solida Biotechnology GmbH
7. Applikon Biotechnology
8. Allergo
9. Celltainer
10. Pierre Guérin
TIPRE00022449
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




christmas_festive_offer

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
Pricing
  • $3000 $2700
  • $4550 $4095
  • $6550 $5568
  • $8550 $6840

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount